“East Meets West”
Comparing Dyslipidemia
Management
in Malaysia Clinical Practice
Guidelines 2023
and
European Society of Cardiology/
European Atherosclerosis Society
Guidelines 2025
By Flora Mac Looi
17/12/2025
,VS
,List of Contents
1. Definition of Dyslipidemia
2. Prevalence of Cardiovascular disease and Dyslipidemia
3. Complications of Dyslipidemia
4. Comparing Dyslipidemia Management in Malaysia CPG 2023 and ESC/ EAS
Guidelines 2025
● Estimation of total cardiovascular risk and treatment goals for LDL
5. Management of Dyslipidemia
6. New Discovery
7. References
, Definition of Dyslipidemia
Dyslipidemia is defined as an alteration in plasma lipid levels that poses
cardiovascular risk, specifically including elevated total cholesterol, low-density
lipoprotein cholesterol (LDL-C), and triglyceride levels, as well as reduced
high-density lipoprotein cholesterol (HDL-C) levels or hypoalphalipoproteinemia.
These dyslipidemias represent substantial risk factors for cardiovascular diseases,
which constitute the leading cause of death globally.
Ballena-Caicedo, J., Zuzunaga-Montoya, F.E., Loayza-Castro, J.A. et al. Global prevalence of dyslipidemias in the general adult population: a systematic review
and meta-analysis. J Health Popul Nutr 44, 308 (2025). https://doi.org/10.1186/s41043-025-01054-3
Comparing Dyslipidemia
Management
in Malaysia Clinical Practice
Guidelines 2023
and
European Society of Cardiology/
European Atherosclerosis Society
Guidelines 2025
By Flora Mac Looi
17/12/2025
,VS
,List of Contents
1. Definition of Dyslipidemia
2. Prevalence of Cardiovascular disease and Dyslipidemia
3. Complications of Dyslipidemia
4. Comparing Dyslipidemia Management in Malaysia CPG 2023 and ESC/ EAS
Guidelines 2025
● Estimation of total cardiovascular risk and treatment goals for LDL
5. Management of Dyslipidemia
6. New Discovery
7. References
, Definition of Dyslipidemia
Dyslipidemia is defined as an alteration in plasma lipid levels that poses
cardiovascular risk, specifically including elevated total cholesterol, low-density
lipoprotein cholesterol (LDL-C), and triglyceride levels, as well as reduced
high-density lipoprotein cholesterol (HDL-C) levels or hypoalphalipoproteinemia.
These dyslipidemias represent substantial risk factors for cardiovascular diseases,
which constitute the leading cause of death globally.
Ballena-Caicedo, J., Zuzunaga-Montoya, F.E., Loayza-Castro, J.A. et al. Global prevalence of dyslipidemias in the general adult population: a systematic review
and meta-analysis. J Health Popul Nutr 44, 308 (2025). https://doi.org/10.1186/s41043-025-01054-3
